Literature DB >> 12860864

QT dispersion and left ventricular morphology in patients with hypertrophic cardiomyopathy.

K Sakata1, M Shimizu, H Ino, M Yamaguchi, H Terai, K Hayashi, M Kiyama, T Hayashi, M Inoue, H Mabuchi.   

Abstract

OBJECTIVE: To evaluate the relation between QT variables and disproportion of left ventricular wall hypertrophy in patients with hypertrophic cardiomyopathy.
DESIGN: Retrospective analysis of the results of echocardiography and electrocardiography.
SETTING: University hospital (tertiary referral centre). PATIENTS: 70 patients with hypertrophic cardiomyopathy were divided into four groups according to the distribution of left ventricular wall hypertrophy on cross sectional echocardiography: group A--hypertrophy confined to the interventricular septum; group B--hypertrophy confined to the interventricular septum and left ventricular anterior wall; group C--hypertrophy confined to the interventricular septum, left ventricular anterior wall, and lateral free wall; group D--hypertrophy involving all portions of the left ventricle. MAIN OUTCOME MEASURES: QT intervals and QT dispersion in precordial six lead ECGs.
RESULTS: There were no significant differences in the maximum left ventricular wall thickness among the four groups, and maximum and minimum QTc intervals also did not differ. QTc dispersion was increased significantly in groups A and B compared with groups C and D. Dispersions of the interval from the J point to the end of the T wave (JTc dispersions) in groups A and B were also increased significantly compared with groups C and D. By linear regression analysis, QTc and JTc dispersions correlated with the ratio of the interventricular septal thickness to left ventricular posterior wall thickness (p = 0.0152 and p = 0.0075, respectively).
CONCLUSIONS: QT dispersion may be affected by not only electrical inhomogeneity but also by morphological inhomogeneity of the left ventricle in patients with hypertrophic cardiomyopathy.

Entities:  

Mesh:

Year:  2003        PMID: 12860864      PMCID: PMC1767760          DOI: 10.1136/heart.89.8.882

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  19 in total

1.  Assessment of QT dispersion as a prognostic marker for sudden death in a regional nonreferred hypertrophic cardiomyopathy cohort.

Authors:  B J Maron; M J Leyhe; S A Casey; T E Gohman; C M Lawler; R S Crow; M S Maron; M Hodges
Journal:  Am J Cardiol       Date:  2001-01-01       Impact factor: 2.778

2.  Importance of lead selection in QT interval measurement.

Authors:  J C Cowan; K Yusoff; M Moore; P A Amos; A E Gold; J P Bourke; S Tansuphaswadikul; R W Campbell
Journal:  Am J Cardiol       Date:  1988-01-01       Impact factor: 2.778

3.  Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death.

Authors:  G Buja; M Miorelli; P Turrini; P Melacini; A Nava
Journal:  Am J Cardiol       Date:  1993-10-15       Impact factor: 2.778

4.  Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.

Authors:  D J Sahn; A DeMaria; J Kisslo; A Weyman
Journal:  Circulation       Date:  1978-12       Impact factor: 29.690

5.  QT dispersion and risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy.

Authors:  G Yi; P Elliott; W J McKenna; K Prasad; S Sharma; X H Guo; A J Camm; M Malik
Journal:  Am J Cardiol       Date:  1998-12-15       Impact factor: 2.778

6.  QT dispersion in sinus beats and ventricular extrasystoles in normal hearts.

Authors:  C P Day; J M McComb; R W Campbell
Journal:  Br Heart J       Date:  1992-01

7.  QT-interval abnormalities in hypertrophic cardiomyopathy.

Authors:  A Dritsas; E Sbarouni; D Gilligan; P Nihoyannopoulos; C M Oakley
Journal:  Clin Cardiol       Date:  1992-10       Impact factor: 2.882

8.  Assessment of QT dispersion in symptomatic patients with congenital long QT syndromes.

Authors:  N J Linker; P Colonna; C A Kekwick; J Till; A J Camm; D E Ward
Journal:  Am J Cardiol       Date:  1992-03-01       Impact factor: 2.778

9.  QT dispersion: an indication of arrhythmia risk in patients with long QT intervals.

Authors:  C P Day; J M McComb; R W Campbell
Journal:  Br Heart J       Date:  1990-06

10.  Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy.

Authors:  P Spirito; P Bellone; K M Harris; P Bernabo; P Bruzzi; B J Maron
Journal:  N Engl J Med       Date:  2000-06-15       Impact factor: 91.245

View more
  5 in total

1.  Fibrosis and wall thickness affect ventricular repolarization dynamics in hypertrophic cardiomyopathy.

Authors:  Mikko Jalanko; Heikki Väänänen; Mika Tarkiainen; Petri Sipola; Pertti Jääskeläinen; Kirsi Lauerma; Tiina Laitinen; Tomi Laitinen; Mika Laine; Tiina Heliö; Johanna Kuusisto; Matti Viitasalo
Journal:  Ann Noninvasive Electrocardiol       Date:  2018-07-04       Impact factor: 1.468

2.  Impact of QT variables on clinical outcome of genotyped hypertrophic cardiomyopathy.

Authors:  Katsuharu Uchiyama; Kenshi Hayashi; Noboru Fujino; Tetsuo Konno; Yuichiro Sakamoto; Kenji Sakata; Masa-aki Kawashiri; Hidekazu Ino; Masakazu Yamagishi
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-01       Impact factor: 1.468

3.  Prolonged QT dispersion in the infants of diabetic mothers.

Authors:  Derya Arslan; Osman Guvenc; Derya Cimen; Havva Ulu; Bulent Oran
Journal:  Pediatr Cardiol       Date:  2014-04-17       Impact factor: 1.655

4.  Late ventricular potentials and QT dispersion in familial dysautonomia.

Authors:  Udi Nussinovitch; Uriel Katz; Moshe Nussinovitch; Naomi Nussinovitch
Journal:  Pediatr Cardiol       Date:  2009-04-02       Impact factor: 1.655

5.  Diffuse interstitial fibrosis assessed by cardiac magnetic resonance is associated with dispersion of ventricular repolarization in patients with hypertrophic cardiomyopathy.

Authors:  David Hurtado-de-Mendoza; Celia P Corona-Villalobos; Iraklis Pozios; Jorge Gonzales; Yalda Soleimanifard; Sanjay Sivalokanathan; Diego Montoya-Cerrillo; Styliani Vakrou; Ihab Kamel; Wilfredo Mormontoy-Laurel; Ketty Dolores-Cerna; Jacsel Suarez; Sergio Perez-Melo; David A Bluemke; Theodore P Abraham; Stefan L Zimmerman; M Roselle Abraham
Journal:  J Arrhythm       Date:  2016-11-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.